Carcinoma of the male breast
Abstract
The article shows five patients suffering from the breast cancer, who were treated at the Surgery Ward, General Hospital in Bjelovar within the period from 1980 until 2002. Male breast cancer is a relatively rare disease. The ratio is 1 in 100.000 of population, and 1% of breast carcinoma, and approximately 1,5% of all maligmant tumors in men. The ratio with our analysed patients is 5:511 or 1,22%. The breast cancer in four cases was in an advanced stage; the age of diagnosis was in average 12,5 years later than for women. A clinical picture showed unilateral, firm formations, placed under the nipple, retracted nipple and ulceration. Pathohistological characheristics of men's breast cancer correspond to the women's breast cancer. For all our patients the pathohistological findings were ductal invasive carcinoma of G1, G2, G3 biological aggressiveness. Diagnostic methods applied in men's braest cancer detecting were: physical checkup, mammography ultrasound, cytological, examination and biopsy. The treatment was determined for each patient individually, and it depended on clinical status of tumor, age and general condition of the patient. The methods of the breast cancer treatment for our male patients were surgical, radiotherapeutic, chemotherapeutic and hormonal. All our patients were operated on. One of the patients had a radical mastectomy, three of them had a modified radical mastectomy and one patients had a simple mastectomy, so called sanitary ablation, witch had a pallative role with an aim to stop further bleeding from the cancer, and to get a pathohystological diagnosis and to improve the quality of life. Final results of the treatment are not favourable for the treatment of all the patients started very late.
Downloads
References
Bašić M, Kvakan D. Bosnar M. Mlinarić I. Značaj mamografije u ranom otkrivanju raka dojke. Libri Oncol 1981; 2-3: 89-91
Bounds WE. Burton GV, Schwalke MA. Male breast cancer. J La State Med Soc 1993; 148: 356-6
El Omari-Alaoui H, Lahdiri I, Nejjar I, Hadadi K, Ahyoud F, Hachi H. Male breast cancer. A report of 71 cases Cancer Radiother 2002; 6(6): 349-51
Ewertz M. Holmberg L. Tretil S. Pedersen BV. Kristensen A. Risk factors for male breast cancer - a case-control study from Scandinavia. Acta Oncol 2001; 40(4): 467-71
Gross PE. Reid C. Pintilie M. Lim R. Miller N. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer 1999; 85(3): 629-39
Hayes T. Pharmacotherapy for male breast cancer.: Expert Opin Pharmacother 2002 Jun; 3(6): 701-8
Incidencija raka u Hrvatskoj: Zavod za zaštitu zdravlja Republike Hrvatske - Registar za rak. Bilten 1-12. Zagreb 1996.
Kubović M. Vladović-Relja T. Prilog problematici karcinoma dojke u muškaraca. Radiol lugoslav 1976; 4: 545-9
Loman N, Johannsson O. BendahI PO. Borg A. Steroid receptor in hereditary breast carcinomas associated with Braca I or Braca 2 mutations or unknown susceptibility genes. Cancer. 1998; 83(2): 310-9
Longhino A. Kirurgija operabilnog i diseminiranog raka dojke. U: 7. Kongres liječnika Hrvatske. Zagreb. Zbor liječnika Hrvatske. 1982; 90-91.
Martinac P. Unušić J. Montani Đ. Smuđ D. Obostrani rak dojke. Libri Oncol 1981; 2-3: 135-8
Meguerditchain An. Falardeau M. Martin G. Male breast carcinoma: Can J Surg 2002; 45(4): 296-302
Montani Đ. Kirurški postupak kod karcinoma dojke; IV. poslijediplomski tečaj iz plastične kirurgije. Zagreb. 1996; 13-17.
Riberio G. Swindell R. Adjuvant tamoxifen for male breast cancer. Br J Cancer 1992; 65:252-4
Rudan N. Izbor operacijskog postupka u liječenju raka dojke stadij l-ll U: Prpić I. Unušić J. (ur.): Dijagnostika i Liječenje raka dojke stadij l-ll; Zbornik radova. HAZU. Zagreb 1994, str. 7-12.
Rudan N. Promjene u koncepciji kirurškog liječenja raka dojke - Gdje smo bili. kamo idemo?: Prpić I. Unušić J (ur.): Rak dojke u XXl. stoljeću.; Zbornik radova. HAZU. Zagreb 2000. str. 26-37.
Rudan N. Rudan I. Prognostic factor in male breast cancer. Libri Oncol 1994; 23: 113-9
Rudan N. Rudan I: Bileteral carcinoma of male breast cancer. Libri Oncol 1993; 22: 149-152
Stanec M. Izbor metode liječenja raka dojke u muškaraca. Magistarski rad. Medicinski fakultet Sveučilišta u Zagrebu. 1998.
Stanec M. Karcinom muške dojke. U: Fajdić J i sur.(ur.). Bolesti dojke. Nakladni zavod Globus. Klinika za tumore. Hrvatska liga protiv raka, Zagreb 1996. str. 619-620.
Strom HH. Olsen J. Risk of breast cancer in offspring of male breast-cancer patient. Lancet 1999; 353(9148):209.
Tomek R. Vukas D. Kemoterapija raka dojke: U Fajdić J i sur.(ur.): Bolesti dojke Nakladni zavod. Globus. Zagreb. 1998. str. 335-337.
Veronesi U, Saccozzi R, Del Vecchio M et al. Comparing radical mastectomy with qudrantectomy. axillary dissection. and radiotherapy in patient with small cancers of the breast. N Eng J Med 1981; 2: 6-11
Vetto J. Schmidt W. Pommier R. Di Tommasio J. Accurate and cost-effective evaluation of breast masses in males. Am JI Surg 1988; 175(5): 383-7
Vladović-Relja T. Hančević J. Rak dojke u muškaraca. Libri Oncol 1976; 2:51-6
Wilsher PC. A comparasion outcome of male breast cancer with female breast cancer: Am J Surg 1997: 173: 3. 185-8
Šamija M, Krajina Z, Purušić A. Radioterapija. Nakladni zavod Globus. 1996; 153-63.
Copyright (c) 2004 Acta Chirurgica Croatica
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby authorize the Acta Chirurgica Croatica (ACC) to publish their work.
The authors are aware that although ACC is Open Access journal, the copyright of all material published is vested in ACC. Open access articles are freely available to read, download, and share from the time of publication under the terms of the Creative Commons License Attribution ‐ NonCommerical No Derivative (CC BY‐NC‐ND) license. This license does not permit reuse for any commercial purposes nor does it cover the reuse or modification of individual elements of the work (such as figures, tables, etc.) in the creation of derivative works without specific permission of ACC and appropriate acknowledgment of its source. The authors permit ACC to allow third parties to copy any part of the work without asking for permission, provided that the reference to the source is given and that this is not done for commercial purposes. Except for copyright, other proprietary rights related to the work (e.g., patent or other rights to any process or procedure) shall be retained by the author. To reproduce any text, figures, tables, or illustrations from this work in future works of their own, the author must obtain written permission from ACC.
Each of the author(s) hereby also grants permission to ACC to use such author’s name and likeness in connection with any past, present or future promotional activity by ACC, including, but not limited to, promotions for upcoming issues or publications, circulation solicitations, advertising or other publications in connection with ACC. Also, each of the author(s) hereby grants permission to ACC to use the manuscript in editorial research related to the improvement of editorial conduct, decision making, and issues related to peer review.
Each of the author(s) hereby releases and shall indemnify and hold harmless ACC and its successors, assigns, licensees, officers, directors, employees, and their respective heirs and representatives from and against any and all liabilities, losses, damages and expenses arising out of any claims of any kind that may be asserted against any of them based in whole or in part on any breach of the author(s)’ representations or warranties herein or in the work or anything contained in the work, including but not limited to any claims for copyright infringement or violation of any rights of privacy or publicity.
